CRSP 60.32 ▼ -1.20% Live Trading Data - Stocknear

CRISPR Therapeutics AG

NASDAQ: CRSP · Real-Time Price · USD
60.32
-0.73 (-1.20%)
At close: Sep 25, 2025, 3:59 PM
60.35
0.05%
After-hours: Sep 25, 2025, 05:10 PM EDT
-1.20%
Bid 43.1
Market Cap 5.49B
Revenue (ttm) 37.36M
Net Income (ttm) -467.8M
EPS (ttm) -5.4
PE Ratio (ttm) -11.17
Forward PE -14.86
Analyst Buy
Dividends n/a
Ask 60.59
Volume 1,747,672
Avg. Volume (20D) 3,175,236
Open 58.94
Previous Close 61.05
Day's Range 58.40 - 61.16
52-Week Range 30.04 - 71.13
Beta 1.81
Ex-Dividend Date n/a

About CRSP

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRSP
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CRSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
CRISPR Therapeutics AG is scheduled to release its earnings on Nov 4, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-6.71%
CRISPR Therapeutics shares are trading lower follo... Unlock content with Pro Subscription
4 months ago
-11.86%
Shares of vaccine and gene therapy stocks are trading lower after FDA Commissioner Marty Makary reportedly named Vinay Prasad as director of the Center for Biologics and Research.